EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 28 / No 8-9 (Août–Septembre 2012) Med Sci (Paris), 28 8-9 (2012) 692-695 References
Free Access
Issue
Med Sci (Paris)
Volume 28, Number 8-9, Août–Septembre 2012
Page(s) 692 - 695
Section Nouvelles
DOI https://doi.org/10.1051/medsci/2012288006
Published online 22 August 2012
  1. Richmond TD, Chohan M, Barber DL. Turning cells red: signal transduction mediated by erythropoietin. Trends Cell Biol 2005 ; 15 : 146–155. [CrossRef] [PubMed] [Google Scholar]
  2. Koury MJ, Bondurant MC. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 1990 ; 248 : 378–381. [CrossRef] [PubMed] [Google Scholar]
  3. Kelley LL, Koury MJ, Bondurant MC, et al. Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: a mechanism for controlled rates of erythrocyte production. Blood 1993 ; 82 : 2340–2352. [PubMed] [Google Scholar]
  4. Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 2004 ; 5 : 343–354. [CrossRef] [PubMed] [Google Scholar]
  5. Levy JE, Jin O, Fujiwara Y, et al. Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nat Genet 1999 ; 21 : 396–399. [CrossRef] [PubMed] [Google Scholar]
  6. Daniels TR, Delgado T, Rodriguez JA, et al. The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin Immunol 2006 ; 121 : 144–158. [CrossRef] [PubMed] [Google Scholar]
  7. Schmidt PJ, Toran PT, Giannetti AM, et al. The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. Cell Metab 2008 ; 7 : 205–214. [CrossRef] [PubMed] [Google Scholar]
  8. Radoshitzky SR, Abraham J, Spiropoulou CF, et al. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature 2007 ; 446 : 92–96. [CrossRef] [PubMed] [Google Scholar]
  9. Li L, Fang CJ, Ryan JC, et al. Binding and uptake of H-ferritin are mediated by human transferrin receptor-1. Proc Natl Acad Sci USA 2010 ; 107 : 3505–3510. [CrossRef] [Google Scholar]
  10. Moura IC, Centelles MN, Arcos-Fajardo M, et al. Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J Exp Med 2001 ; 194 : 417–425. [CrossRef] [PubMed] [Google Scholar]
  11. Moura IC, Arcos-Fajardo M, Sadaka C, et al. Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. J Am Soc Nephrol 2004 ; 15 : 622–634. [CrossRef] [PubMed] [Google Scholar]
  12. Matysiak-Budnik T, Moura IC, Arcos-Fajardo M, et al. Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. J Exp Med 2008 ; 205 : 143–154. [CrossRef] [PubMed] [Google Scholar]
  13. Duchez S, Amin R, Cogne N, et al. Premature replacement of mu with alpha immunoglobulin chains impairs lymphopoiesis and mucosal homing but promotes plasma cell maturation. Proc Natl Acad Sci USA 2010 ; 107 : 3064–3069. [CrossRef] [Google Scholar]
  14. Rizzo JD, Brouwers M, Hurley P, et al. American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. J Clin Oncol 28 : 4996–5010. [Google Scholar]
  15. Bohlius J, Schmidlin K, Brillant C, et al. Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. Lancet 2009 ; 373 : 1532–1542. [CrossRef] [PubMed] [Google Scholar]
  16. Leyland-Jones B, Semiglazov V, Pawlicki M, et al. Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study. J Clin Oncol 2005 ; 23 : 5960–5972. [CrossRef] [PubMed] [Google Scholar]
  17. Liang K, Esteva FJ, Albarracin C, et al. Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation. Cancer Cell 2010 ; 18 : 423–435. [CrossRef] [PubMed] [Google Scholar]
  18. Pasquier B, Launay P, Kanamaru Y, et al. Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM. Immunity 2005 ; 22 : 31–42. [PubMed] [Google Scholar]
  19. Nicolas G, Vaulont S. Le mécanisme d’action de l’hepcidine déchiffré. Med Sci (Paris) 2005 ; 21 : 7–9. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  20. Coulon S, Dussiot M, Grapton D, et al. Polymeric IgA1 controls erythroblast proliferation and accelerates erythropoiesis recovery in anemia. Nat Med 2011 ; 17 : 1456–1465. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.